- Company launched as sister company to BioDuro for protein therapeutics -
SAN DIEGO, Calif., March 29, 2007. BioAtla announced that its operations in San Diego and Beijing will be the first to provide global contract services solely focused on protein therapeutics.
Founded by Dr. Jay M. Short, Dr. Masood Tayebi and Carolyn Anderson, the company is following the successful strategy implemented by their earlier sister company, BioDuro, who found that it could increase the odds of success for early stage biotech companies by allowing them to outsource several key functions in combinatorial chemistry and clinical trials.
Protein therapeutics, specifically antibodies, is the fastest growing sector of the pharmaceutical industry. BioAtla’s 4th generation protein optimization technologies combined with a multinational professional staff will enable biotech startups and major pharmaceutical companies to cost effectively accelerate their protein-based drug programs.
About BioAtla, LLC
BioAtla, LLC is a global, biology outsourcing services provider based in San Diego, CA with significant research operations in San Diego, New York, Beijing and expanding in 2011. We are a pioneer in BioAcceleration™ – using a global infrastructure to deliver cost-efficient access to state-of-the art technologies and services, maximizing antibody and other protein product development opportunities for our client partners.
Our exclusive manufacturing partnership with China-based BioDuro, a PPD company, and our intellectual property partnership with Capia IP translates our industry know-how and thought leadership into tangible, ownable results for our clients.
For more information, please visit www.bioatla.com or contact:
Carolyn Anderson, Executive Vice President
SOURCE BioAtla, LLC